Thyrocare Tech and Dr. Lal PathLabs shares rise 9% each:
To begin with, the share value of the Thyrocare Tech and Dr. Lal PathLabs raised 9% each in today’s intraday trade. When the Indian government allowed the private companies for the COVID-19 testing process, the company shares climbed.
Moreover, in India, the number of Covid-19 diseases spread rapidly and positive cases increasing continuously. The govt also searching for the possibility to allow the private laboratories for the ramp-up testing.
The Indian Council of Medical Research has a testing center for the entire coronavirus cases in India. Across India, 52 viral research and diagnostic laboratories are testing the COVID-19 cases.
The VRDLs marshaling resources and setting standards monitoring by the NIV at Pune. On 18th March, one more positive case tested in Pune. Presently, the total number of positive cases reached 18 in Pune and 42 cases in Maharashtra. Totally, in India, 147 coronaviruses positive cases reported from various places in our country.
At 11:00 am, the Lal PrathLabs shares traded at Rs 1,549.85 with a gain of 3.17% or Rs 47.55 per share. Similarly, the Thyrocare Tech traded at Rs 569.50 with a growth of 5.67% or Rs 30.55 per eq share.
Thyrocare Technologies Ltd shares trading with a loss of 43.10 points reached 494.00 INR with 7.89% down. Its previous close at 536.30 INR. Thyrocare Technologies Ltd shares outstanding with 52,836,001.
Dr. Lal PathLabs Ltd shares trading with a loss of 22.20 points reached 1,523.80 INR with 1.48 % down. Its previous close at 1,502.60 INR on National Stock Exchange. Dr. Lal PathLabs Ltd shares outstanding with 82,436.953.
